Akkure Genomics' Cancer Trial Matcher is a model that matches patients and patient cohorts to potentially suitable cancer trials according to the trial’s eligibility criteria and patient data. By leveraging genomic variant types along with AI, Akkure brings a precision match for clinical trials. The system also features ongoing alerts to new trials matched to the patient, and our enterprise version features a smart contract system that captures informed consent digitally, ensuring organisations are compliant and auditable by leveraging blockchain technology​​.